Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Hepatitis B Virus X ÇüÁúÀüȯ »ýÁã¿Í ÀÎü °£¼¼Æ÷¾ÏÁ¾¿¡¼­ Proliferating Cell Nuclear Antigen ¹ßÇö°ú ÀÚ¸ê»ç A Study on the Expression of Proliferating Cell Nuclear Antigen and Apoptosis of theHepatocellular Carcinoma in Human and Hepatitis B Virus X Transgenic Mice

´ëÇѺ´¸®ÇÐȸÁö 2001³â 35±Ç 2È£ p.129 ~ 136
¹®Çü¹è, À¯´ë¿­, À¯Çü·û, ¼Òº´ÁØ, ä±Ç¹¬, ±èÇÐö, À±±âÁß, ÇÑ¿øö, Á¶ÇâÁ¤, ±èº¸¿ë,
¼Ò¼Ó »ó¼¼Á¤º¸
¹®Çü¹è ( Moon Hyung-Bae ) 
¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

À¯´ë¿­ ( Yu Dae-Yeul ) 
»ý¸í°øÇבּ¸¼Ò
À¯Çü·û ( Yoo Hyung-Ryun ) 
¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
¼Òº´ÁØ ( So Byung-Joon ) 
¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
ä±Ç¹¬ ( Chae Kwon-Mook ) 
¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü°úÇб³½Ç
±èÇÐö ( Kim Haak-Cheol ) 
¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
À±±âÁß ( Yun Ki-Jung ) 
¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
ÇÑ¿øö ( Han Won-Cheol ) 
¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
Á¶ÇâÁ¤ ( Jo Hyang-Jeong ) 
¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç
±èº¸¿ë ( Kim Bo-Yong ) 
¿ø±¤´ëÇб³ ÀÇ°ú´ëÇÐ º´¸®Çб³½Ç

Abstract


Background: This experiment was designed to study the cell kinetics of hepatocellular carcinoma (HCC) in both hepatitis B virus X (HBx) transgenic mice and humans.

Methods: The immunohistochemical stain of proliferating cell nuclear antigen (PCNA) and TdT-mediated dUTP-biotin nick end labeling (TUNEL) assay of apoptosis were used on formalin fixed-paraffin embedded tissues.

Results: PCNA labeling indices (PCNA-LI) in the liver of HBx transgenic mice were markedly increased in HCC (11.3%) compare to the dysplastic areas (1.3%) and in the liver of non-transgenic littermates (0.1%). There was no significant difference of PCNA-LI in the dysplastic areas between HCC developed mice and non-HCC developed mice. Apoptosis labeling indices (Apoptosis-LI) in both the dysplastic areas and HCC of HBx transgenic mice were similar to those of non-transgenic littermates. PCNA-LI was markedly increased in human HCC (28.9%) compare to the background of HCC (2.9%) and the control liver (2.9%). Apoptosis-LI was decreased in human HCC (0.3%) compare to the background of HCC (0.4%) and the control liver (1.0%).

Conclusion: There is a marked increase of cell proliferating activity in human HCC and in HCC of HBx transgenic mice, and there is a decrease of apoptosis in human HCC, but not in HCC of HBx transgenic mice.

Å°¿öµå

Transgenic;Hepatocellular;Carcinoma;Proliferating cell nuclear antigen;Apoptosis

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS